# Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary Bypass

> **NCT00297245** · PHASE4 · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 200 (—)

## Conditions studied

- Cognitive Decline

## Interventions

- **DRUG:** cognitive function

## Key facts

- **NCT ID:** NCT00297245
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297245, "Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00297245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*